دورية أكاديمية
Defining the Criteria for Reflex Testing for BRAF Mutations in Cutaneous Melanoma Patients
| العنوان: | Defining the Criteria for Reflex Testing for BRAF Mutations in Cutaneous Melanoma Patients |
|---|---|
| المؤلفون: | Zhou, Sarah, Sikorski, Daniel, Xu, Honghao, Zubarev, Andrei, Chergui, May, Lagacé, François, Miller, Wilson H., Redpath, Margaret, Ghazal, Stephanie, Butler, Marcus O., Petrella, Teresa M., Claveau, Joël, Nessim, Carolyn, Salopek, Thomas G., Gniadecki, Robert, Litvinov, Ivan V. |
| بيانات النشر: | University of Toronto |
| سنة النشر: | 2021 |
| المجموعة: | University of Toronto: Research Repository T-Space |
| الوصف: | Targeted therapy has been developed through an in-depth understanding of molecular pathways involved in the pathogenesis of melanoma. Approximately ~50% of patients with melanoma have tumors that harbor a mutation of the BRAF oncogene. Certain clinical features have been identified in BRAF -mutated melanomas (primary lesions located on the trunk, diagnosed in patients <50, visibly pigmented tumors and, at times, with ulceration or specific dermatoscopic features). While BRAF mutation testing is recommended for stage III–IV melanoma, guidelines differ in recommending mutation testing in stage II melanoma patients. To fully benefit from these treatment options and avoid delays in therapy initiation, advanced melanoma patients harboring a BRAF mutation must be identified accurately and quickly. To achieve this, clear definition and implementation of BRAF reflex testing criteria/methods in melanoma should be established so that patients with advanced melanoma can arrive to their first medical oncology appointment with a known biomarker status. Reflex testing has proven effective for a variety of cancers in selecting therapies and driving other medical decisions. We overview the pathophysiology, clinical presentation of BRAF -mutated melanoma, current guidelines, and present recommendations on BRAF mutation testing. We propose that reflex BRAF testing should be performed for every melanoma patient with stages ≥IIB. |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | application/pdf |
| اللغة: | unknown |
| العلاقة: | Cancers 13 (9): 2282 (2021); http://hdl.handle.net/1807/105740Test |
| DOI: | 10.3390/cancers13092282 |
| الإتاحة: | https://doi.org/10.3390/cancers13092282Test http://hdl.handle.net/1807/105740Test |
| حقوق: | Attribution 4.0 International ; https://creativecommons.org/licenses/by/4.0Test/ |
| رقم الانضمام: | edsbas.8B513B89 |
| قاعدة البيانات: | BASE |
| DOI: | 10.3390/cancers13092282 |
|---|